Wiesława Dominika Wranik (W Dominika Wranik, Dominika Wranik)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Current oncology (Toronto, Ont.)

Human resources for health

Health economics review

BMC health services research

Dalhousie University

University of Manitoba (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dalhousie University Jul 01 2011

Canada

Associate Professor :: School of Public Administration/ Department of Community Health and Epidemiology

SGH Warszaw School of Economics Sep 01 2017 - Aug 31 2018

Poland

Associate Research Fellow / Adiunkt Naukowy :: Zakład Wspomagania i Analizy Decyzji

Dalhousie University Jul 01 2004 - Jun 30 2011

Canada

Assistant Professor :: School of Public Administration

Education History

University of Manitoba - May 01 2005

Canada

PHD :: Economics

Publications

Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Pam Takhar, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E Mercer, Avram E Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, Darryl Boehm, Carole Chambers, Erica Craig, Maureen Trudeau, Matthew C Cheung, Joanne Houlihan, Valerie McDonald, Petros Pechlivanoglou, Marianne Taylor, Eric Wasylenko, Wiesława Dominika Wranik, Kelvin K W Chan
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current oncology (Toronto, Ont.) 31 (4) (2024)
Wiesława Dominika Wranik, Ronaldo-Raul Székely, Susanne Mayer, Mickaël J C Hiligsmann, Kei-Long Cheung
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach. Journal of medical economics 24 (1) (2021)
Christopher Skedgel, Wiesława Dominika Wranik, Min Hu
The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017. PharmacoEconomics 36 (4) (2019)
Wiesława Dominika Wranik, Susan Marie Haydt
Funding models and medical dominance in interdisciplinary primary care teams: qualitative evidence from three Canadian provinces. Human resources for health 16 (1) (2018)
Wiesława Dominika Wranik, Christopher Skedgel, Min Hu
Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders. Expert review of pharmacoeconomics & outcomes research 19 (1) (2018)
Wiesława Dominika Wranik, Adam Muir, Min Hu
Costs of productivity loss due to occupational cancer in Canada: estimation using claims data from Workers' Compensation Boards. Health economics review 7 (1) (2017)
Wiesława Dominika Wranik, Susan M Haydt, Alan Katz, Adrian R Levy, Maryna Korchagina, Jeanette M Edwards, Ian Bower
Funding and remuneration of interdisciplinary primary care teams in Canada: a conceptual framework and application. BMC health services research 17 (1) (2017)

Wiesława Dominika Wranik.css-eqlu8i{font-size:small;padding-left:4px;} (W Dominika Wranik, Dominika Wranik)

Publication Activity (10 Years)

Top Topics

Top Venues

Wiesława Dominika Wranik (W Dominika Wranik, Dominika Wranik)